Summit on Controversies in Precision Medicine
In-Person Event
Nov 13 - 15, 2017
Berlin, Berlin, DE
OVERVIEW
Summit on Controversies in Precision Medicine is organized by Kenes Turkey and would be held during Nov 13 - 15, 2017 at Ameron Hotel Abion Spreebogen Waterside, Berlin, Germany.
Precision medicine aims to individualise therapeutic interventions, based on OMICS data such as genomics, proteomics, metabolomics etc’, profiling together with histopathological insights to the type, stage, and the grade of the disease, as well as on the potential response of a particular patient to a particular treatment regimen. With next generation sequencing technologies, it is now possible to identify all germline variants of an individual at an affordable cost and thus paving the way for clinicians to provide healthcare from an individual perspective. However, the data that correlate specific disease type, response to specific treatment, and adverse effects as a result of the treatment, are slow to come. There are also critical voices warning us of getting lost in Big Data and advocating a stronger role of physiological models and phenotypic data in drug R&D. Another dimension of this debate is related to the way many companies manage their precision medicine processes and strategies for developing a more agile approach in the field.
Additional details will be posted as soon as they are available.
Precision medicine aims to individualise therapeutic interventions, based on OMICS data such as genomics, proteomics, metabolomics etc’, profiling together with histopathological insights to the type, stage, and the grade of the disease, as well as on the potential response of a particular patient to a particular treatment regimen. With next generation sequencing technologies, it is now possible to identify all germline variants of an individual at an affordable cost and thus paving the way for clinicians to provide healthcare from an individual perspective. However, the data that correlate specific disease type, response to specific treatment, and adverse effects as a result of the treatment, are slow to come. There are also critical voices warning us of getting lost in Big Data and advocating a stronger role of physiological models and phenotypic data in drug R&D. Another dimension of this debate is related to the way many companies manage their precision medicine processes and strategies for developing a more agile approach in the field.
Additional details will be posted as soon as they are available.
KEY DATES
13 Nov, 2017
Event Start Date
15 Nov, 2017
Event End Date
SUGGESTED HOTELS
CONFERENCE VENUE
Ameron Hotel Abion Spreebogen WatersideQuick Links